These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


433 related items for PubMed ID: 9550642

  • 1. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H, Blohmé G, Grände B, Björck S.
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [Abstract] [Full Text] [Related]

  • 2. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S, Blohmé G, Sylvén C, Mulec H.
    Nephrol Dial Transplant; 1997 Mar; 12 Suppl 2():67-70. PubMed ID: 9269704
    [Abstract] [Full Text] [Related]

  • 3. Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin-dependent diabetic patients.
    Earle KA, Morocutti A, Viberti G.
    J Hypertens; 1997 Feb; 15(2):191-6. PubMed ID: 9469795
    [Abstract] [Full Text] [Related]

  • 4. Monitoring glomerular function in diabetic nephropathy. A prospective study.
    Viberti GC, Bilous RW, Mackintosh D, Keen H.
    Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
    [Abstract] [Full Text] [Related]

  • 5. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes.
    Thomson HJ, Ekinci EI, Radcliffe NJ, Seah JM, MacIsaac RJ, Jerums G, Premaratne E.
    J Diabetes Complications; 2016 Mar; 30(2):256-61. PubMed ID: 26794645
    [Abstract] [Full Text] [Related]

  • 6. Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?
    Farmer CK, Goldsmith DJ, Quin JD, Dallyn P, Cox J, Kingswood JC, Sharpstone P.
    Nephrol Dial Transplant; 1998 Mar; 13(3):635-9. PubMed ID: 9550639
    [Abstract] [Full Text] [Related]

  • 7. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 8. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Parving HH, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS.
    Diabetologia; 1984 Dec 07; 27(6):547-52. PubMed ID: 6442240
    [Abstract] [Full Text] [Related]

  • 9. Premature cell ageing and evolution of diabetic nephropathy.
    Morocutti A, Earle KA, Rodemann HP, Viberti GC.
    Diabetologia; 1997 Feb 07; 40(2):244-6. PubMed ID: 9049488
    [Abstract] [Full Text] [Related]

  • 10. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy?
    Lervang HH, Jensen S, Brøchner-Mortensen J, Ditzel J.
    Diabet Med; 1992 Feb 07; 9(7):635-40. PubMed ID: 1511570
    [Abstract] [Full Text] [Related]

  • 11. Improved prognosis of diabetic nephropathy in type 1 diabetes.
    Andrésdóttir G, Jensen ML, Carstensen B, Parving HH, Hovind P, Hansen TW, Rossing P.
    Kidney Int; 2015 Feb 07; 87(2):417-26. PubMed ID: 24918158
    [Abstract] [Full Text] [Related]

  • 12. Monitoring kidney function in diabetic nephropathy.
    Rossing P, Astrup AS, Smidt UM, Parving HH.
    Diabetologia; 1994 Jul 07; 37(7):708-12. PubMed ID: 7958543
    [Abstract] [Full Text] [Related]

  • 13. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetes; 1993 May 07; 42(5):715-9. PubMed ID: 8482428
    [Abstract] [Full Text] [Related]

  • 14. Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy.
    Mathiesen ER, Hommel E, Olsen UB, Parving HH.
    Diabet Med; 1988 Mar 07; 5(2):145-9. PubMed ID: 2964980
    [Abstract] [Full Text] [Related]

  • 15. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.
    Rave K, Bender R, Heise T, Sawicki PT.
    J Hypertens; 1999 May 07; 17(5):597-601. PubMed ID: 10403602
    [Abstract] [Full Text] [Related]

  • 16. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
    Bruce R, Williams L, Cundy T.
    Aust N Z J Med; 1994 Aug 07; 24(4):390-5. PubMed ID: 7980236
    [Abstract] [Full Text] [Related]

  • 17. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J.
    Acta Med Scand Suppl; 1988 Aug 07; 722():1-69. PubMed ID: 3163465
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy and progression of diabetic nephropathy.
    Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH.
    Diabetologia; 2002 Jan 07; 45(1):36-41. PubMed ID: 11845221
    [Abstract] [Full Text] [Related]

  • 19. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 07; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 20. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetologia; 1994 May 07; 37(5):511-6. PubMed ID: 8056190
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.